The estrous cycle of the Control group was characterized by four regular phases (Fig. 8C), whereas the PCOS and Candesartan (AT1R inhibitor) groups showed disordered cycles (Fig. 8D, E). The gene discussed is AGTR1; the disease is polycystic ovary syndrome.